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Abstract
Objectives—Data on the acquisition of human papillomavirus (HPV) infection in men are
limited, especially from developing regions including Africa. The objective of this study was to
characterise and determine the risk factors of HPV acquisition among a cohort of uncircumcised
men participating in a randomised controlled trial (RCT) of male circumcision in Kisumu, Kenya.
Methods—Penile exfoliated cell specimens were collected at baseline, 6- and 12-month follow-
up visits from the glans/coronal sulcus and shaft of men enrolled in the control arm of the RCT
between 2002 and 2005. All participants were HIV seronegative, aged 17–24 years at baseline and
remained uncircumcised over follow-up. Specimens were tested with GP5+/6+ PCR to detect 44
HPV types. Parametric frailty models were used to assess risk factors of HPV incidence.
Results—The median age of 966 participants was 20 years. The median follow-up time was 12.1
months. The incidence rate (IR) of any HPV infection was 49.3/1000 person-months with HPV16
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having the highest IR (10.9/1000 person-months). The strongest risk factors for overall HPV
incidence were bathing less frequently than daily (adjusted HR=2.6; 95% CI 1.0 to 6.5) and
having ≥2 female sexual partners in the past year (adjusted HR=1.6; 95% CI 1.2 to 2.1).
Conclusions—HPV IRs were notably high in this cohort of high-risk, uncircumcised men from
Kisumu, Kenya, with the number of sexual partners and bathing frequency being the strongest risk
factors.
INTRODUCTION
Carcinogenic human papillomavirus (HPV) infections are necessary for the development of
invasive cervical cancer and are considered aetiological agents of other non-cervical cancers
among both men and women.1–4 While several previous studies have described HPV
infections among women, data on the acquisition of HPV infection among men are
relatively limited.5
Few prospective studies have been published on HPV incidence among men from North
America, South America, Europe and Africa.6–14 Incidence rates (IRs) of penile HPV
infections for the first incident HPV type detected have ranged from 17.9 to 38.4/1000
person-months.6–8, 14 Determining risk factors for HPV incidence among men could identify
interventions to help prevent future HPV acquisition in men and transmission to women. A
higher number of recent and lifetime sexual partners and history of smoking have been
found to increase the rate for HPV acquisition among men in prior studies.7, 14, 15 Data are
especially needed on the rate and risk factors of HPV acquisition among men in less
developed geographical regions, including sub-Saharan Africa, where the incidence of
invasive cervical cancer among women is among the highest worldwide.16, 17
Randomised controlled trials (RCTs) of male circumcision have shown that circumcision
reduces HPV acquisition among men.10, 18 Given that some men may remain uncircumcised
due to lack of access to services, religion or other reasons, we sought to characterise the
type-specific incidence of HPV infection over a 12-month period among 966 uncircumcised
men participating in the control arm of an RCT of male circumcision in Kisumu, Kenya. We
also aimed to determine risk factors for HPV acquisition using parametric frailty models
allowing for the analysis of clustered survival data.
METHODS
Study population and enrolment
Uncircumcised men were screened between February 2002 and September 2005 in Kisumu,
Kenya, to participate in an RCT of male circumcision.19 The primary aim of the RCT was to
determine the efficacy of male circumcision in reducing HIV incidence. In brief, inclusion
criteria included being uncircumcised, aged 18–24 years, HIV seronegative and sexually
active. Participants were recruited from sexually transmitted infection clinics, workplaces
and community organisations. The study protocol was approved by the Institutional Review
Boards of the Universities of Illinois at Chicago, Manitoba, Nairobi and North Carolina; RTI
International; and the VU University Medical Center.
Questionnaire and specimen collection
After undergoing informed consent, participants were administered a standardised
questionnaire on sociodemographic characteristics, hygiene practices, including how often
they normally bathe (once/week, twice/week, every 2 days, every day), and sexual
behaviour by a trained male interviewer. Penile exfoliated cells were collected for HPV
DNA detection at baseline, 6- and 12-month study visits. At each visit, specimens were
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taken separately from two anatomical sites: (i) shaft and external foreskin tissue (shaft
specimen) and (ii) glans, coronal sulcus and inner foreskin tissue (glans specimen) using
prewetted Type 3 Dacron swabs (Roche Diagnositics, Basel, Switzerland).20
Penile cell samples were placed into two individual 15 ml conical centrifuge tubes
containing 2 ml 0.01 mol/l Tris-HCl, 7.4 pH, buffer and processed on the day of collection
at the clinical laboratory of the Universities of Nairobi, Illinois and Manitoba by
centrifugation at high speed (maximum, 3000 g) for 10 min. Excess Tris-HCl buffer was
discarded using a Pasteur pipette, and the remaining cell pellet was resuspended in Tris-HCl
buffer, and vortexed. Diluted cell pellets were frozen at −75°C. All samples were sent using
a dry shipper to the Department of Pathology, VU University Medical Center, Amsterdam,
The Netherlands, for HPV DNA testing.
HPV DNA and sexually transmitted infection testing
DNA was isolated from penile exfoliated cell samples using NucleoSpin 96 Tissue kit
(Macherey-Nagel, Germany) and a Microlab Star robotic system (Hamilton, Germany),
according to manufacturers’ instructions. Presence of human DNA was evaluated by β-
globin-specific PCR followed by agarose gel electrophoresis. HPV positivity was assessed
by GP5+/6+ PCR followed by hybridisation of PCR products using an enzyme
immunoassay readout with two HPV oligoprobe cocktail probes that, together, detect 44
HPV types. Subsequent genotyping was performed by reverse line blot (RLB) hybridisation
of PCR products, as described previously.21, 22 HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56,
58, 59, 66 and 68 were considered high-risk types. Low-risk types included all other HPV
types. HPV types detected by enzyme immunoassay, but not by RLB genotyping, were
designated as HPV-X, indicating a type, subtype or variant not detectable with probes used
for RLB hybridisation.
At the baseline visit, urine samples were tested for Neisseria gonorrhoeae and Chlamydia
trachomatis infections by PCR-based methods (Roche Diagnostics, Basel, Switzerland).
Serum specimens were tested for herpes simplex virus type 2 (HSV-2) antibody (Kalon
Biological, Aldershot, UK).
Statistical methods
Inclusion criteria required men to be enrolled in the control arm of the RCT, have HPV
DNA results available from the baseline and 6-month visits, and remain uncircumcised until
the 6-month visit. Of 1393 uncircumcised men enrolled in the control arm, 1140 had an
HPV test result at baseline, of which 972 also had an HPV result from the 6-month visit. Of
these, 966 men remained uncircumcised until the 6-month visit and were included in
analyses. HPV prevalence at baseline and IRs for HPV detected over the 12-month follow-
up period were estimated for individual HPV types and for specific HPV type groupings (eg,
any HPV, high-risk HPV). An incident, or acquired, infection was defined as detection of a
type-specific HPV infection during follow-up that was not present at baseline.
The time at risk of acquiring an incident HPV infection at either anatomical site was
estimated assuming the incident infection was acquired at the midpoint between the last
HPV-negative result and first HPV-positive result. Participants were censored at their last
visit prior to circumcision if they were circumcised before their 12-month visit or at their
last study visit if they remained HPV-negative. IR estimates for each HPV type or type
grouping were estimated only among participants who were negative for the given
individual type or grouping at baseline. Men with multiple HPV types were considered to
have a high-risk HPV infection if ≥1 high-risk types were detected and a low-risk infection
if only low-risk types were detected. Acquisition of multiple high-risk HPV types at the
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same visit was considered a single acquisition event. Men with untyped HPV infections
were excluded from high-risk and low-risk categorisations unless a high-risk type was
concurrently detected. IR analyses were repeated for any, high-risk and low-risk HPV for
the glans and shaft specimens separately. Confidence intervals (CIs) for IRs were estimated
by modelling the number of incident HPV infections as a Poisson variable.6, 23 Hazard ratios
(HRs) comparing IRs for high-risk versus low-risk HPV infections and for glans versus shaft
infections were estimated using the Wei–Lin–Weissfeld method to adjust for correlated data
within subjects.24
HRs and corresponding 95% CIs for potential risk factors of HPV incidence, among men
who were HPV negative at baseline, were estimated via age-adjusted parametric frailty
models assuming a Weibull distribution and allowing one man to contribute >1 incident
infection to analyses.25 HPV infections were right censored if they were not detected during
follow-up. All other HPV infections were interval censored with the upper limit of the
interval corresponding to the visit the infection was first detected and the lower limit
corresponding to the last visit where the infection was absent. Multivariate parametric frailty
models were used to estimate adjusted HRs and 95% CIs. The full multivariate model
included age (≤19, 20–21, ≥22 years), condom use in the last 6 months and education,
believed a priori to be variables of interest, and variables with significant marginal
associations for HPV incidence (employment status, bathing frequency and number of
sexual partners in the past 12 months (≤1, ≥2 partners)). The final multivariate model
included age and variables remaining significant in the multivariate model after a backwards
elimination process. Statistical significance was determined by likelihood ratio tests. Age-
adjusted and final multivariate models were then estimated using high-risk HPV incidence
as the outcome.
β-Globin positivity in the glans and shaft specimens was 57.7% and 36.0% at baseline,
57.9% and 35.8% at the 6-month visit, and 68.3% and 46.3% at the 12-month visit,
respectively. Results did not differ substantially when analyses were restricted to β-globin-
positive samples; thus, reported analyses used HPV DNA data from all penile exfoliated cell
specimens unless otherwise stated.
RESULTS
The median age of the 966 participating men at enrolment was 20 years (range 17–24) (table
1). Most men did not live with their sexual partner at baseline (94.6%) and had at least a
secondary education (63.6%). No participant reported having a male sexual partner.
Approximately a quarter (25.8%) of men reported never using a condom in the past 6
months. The prevalence of HSV-2 seropositivity was 26.5%, with Chlamydia trachomatis
(4.0%) and Neisseria gonorrhoeae (1.6%) laboratory-diagnosed infections being less
common.
Overall baseline prevalence of HPV infection was 50.1%, with multiple HPV infections
found among 29.0% of participants (table 2). High-risk and low-risk HPV infections were
detected in 37.5% and 10.6% of participants, respectively, at baseline. The four most
common HPV types were HPV16 (9.9%), 56 (6.3%), 67 (5.8%) and 52 (5.4%) within single
or multiple infections. All other known HPV types detected had a prevalence of <5%.
The median time of study follow-up was 12.1 months (inter-quartile range (IQR) 0.5),
including 65 (7%) of men who had two visits and 901 (93%) with three visits. The median
time between study visits was 6.1 months (IQR 0.4) from baseline to the 6-month visit, and
6.0 months (IQR 0.2) from the 6- to 12-month visits.
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The IR of any HPV infection was 49.3/1000 person-months for the first HPV type detected
at either the glans or shaft (table 2). Incident infections of multiple HPV types were common
with an incidence of 24.3/1000 person-months. The IR of high-risk HPV was higher than
low-risk HPV (HR=1.6; 95% CI 1.3 to 2.0). The individual types with the highest IRs in
either single or multiple infections were HPV16 (10.9/1000 person-months), HPV35
(6.0/1000 person-months), HPV JC9710 (6.0/1000 person-months) and HPV56 (5.5/1000
person-months). All other HPV types had IRs ≤5.0/1000 person-months.
The incidence of any HPV infection was 44.4/1000 person-months in the glans compared
with 21.6/1000 person-months in the shaft (HR=2.1; 95% CI 1.7 to 2.4) (table 3). IRs of
high-risk and low-risk infections in the glans were 27.3 and 18.8/1000 person-months,
respectively, with lower rates for high-risk and low-risk HPV infections in the shaft (13.1
and 7.8/1000 person-months, respectively). The incidence of multiple HPV type infections
was higher in the glans versus shaft (HR=2.9; 95% CI 2.3 to 3.6). When restricting analyses
to β-globin-positive samples, IRs for overall HPV in the glans and shaft (47.9 and 22.4/1000
person-months, respectively) were similar to the corresponding IRs observed among all
samples.
Risk factors for HPV incidence
The strongest risk factors for incident HPV infections in age-adjusted models were bathing
less frequently than daily (HR=3.0; 95% CI 1.2 to 7.9), having ≥2 female sexual partners in
the year prior to enrolment (HR=1.6; 95% CI 1.2 to 2.2) and being employed (HR=1.4; 95%
CI 1.1 to 1.9) (table 4). Other potential risk factors assessed, including HSV-2 seropositivity,
living with one’s partner and condom use in the last 6 months, were not significantly
associated with HPV IRs. In the final model, having ≥2 sexual partners in the past year
(HR=1.6; 95% CI 1.2 to 2.1) remained associated with HPV incidence, after controlling for
age, employment status and bathing frequency. Less frequent bathing (HR=2.6; 95% CI 1.02
to 6.5) and employment status (HR=1.4; 95% CI 1.1 to 1.9) also remained significant in the
final model. Results were similar when modelling incident high-risk HPV infections as the
outcome in both age-adjusted and multivariate models, except that employment status was
not significant in the final model (table 4).
When analyses were restricted to β-globin-positive samples, the associations between
overall HPV incidence and bathing frequency (HR=4.7; 95% CI 1.6 to 14.2) and the number
of partners in the last 12 months (HR=1.8; 95% CI 1.2 to 2.6) remained significant albeit
less precise, after adjusting for age, bathing frequency and number of sexual partners.
Employment status, however, was no longer significant in the age-adjusted model (HR=1.3;
95% CI 0.9 to 2.0). Bathing frequency and the number of sexual partners in the past 12
months remained strong risk factors when modelling incident high-risk HPV as the outcome
among β-globin-positive samples (results not shown).
DISCUSSION
Incident HPV infections were common among Kenyan men, with an IR of almost 50/1000
person-months. The incidence of high-risk HPV infections in the glans was higher than the
incidence of low-risk infections in the glans and of HPV infections in the shaft. The
strongest risk factors for overall HPV incidence were having at least two sexual partners in
the year prior to enrolling in the RCT and bathing less frequently than daily.
This is the largest follow-up study of HPV infection, to our knowledge, among
uncircumcised men to date. It is also one of the first to determine risk factors for
HPVacquisition among men from sub-Saharan Africa. A sensitive GP5+/6+ PCR assay was
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used to detect a wide range of HPV types in a central laboratory, and separate HPV
laboratory testing for glans and shaft specimens allowed for stratified analyses by
anatomical site. Novel parametric frailty models were used to assess several potential risk
factors for HPV acquisition, which allow for the analysis of clustered survival data using
arbitrary censoring.25
The IR of 49.3/1000 person-months found in our study is higher than previously reported IR
estimates among men, ranging from 17.9/1000 person-months among military men from
Mexico to 38.4/1000 person-months among men from Brazil, Mexico and the USA.6–8, 14
The higher IR in our study could be due in part to the longer duration of 1 year between
visits in the study from Mexico,8 which may have underestimated the true IR, and the lower
percentage of uncircumcised men in the international and US studies.6, 7, 14 Our IR estimate
for high-risk HPV infection in the glans (27.3/1000 person-months, equivalent to 32.8/100
person-years) was slightly higher than the corresponding IR in the glans among HIV-
negative, married men participating in the control arm of an RCT of male circumcision in
Uganda (IR=29.4/100 person-years).10 The slightly higher IR found in our Kenyan study
could be due to differences in age and marital status as the Uganda study had a higher
median age and only included married participants.
HPV16, the most prevalent HPV type in this population (9.9%), also had the highest
incidence (10.9/1000 person-months). A high incidence of HPV16 has been similarly
reported in other studies among both men6, 7, 9, 14 and women.26 The high rate of acquisition
of HPV16 has a clear implication for increasing cancer risk among men and their sexual
partners, as HPV16 is the most common HPV type found in penile cancer among men;2
cervical, vulvar and vaginal cancers among women;1, 27 and in anal and oropharyngeal
cancers in both sexes.3, 4
Penile HPV IRs in our study were higher in the glans specimen, including the inner foreskin,
compared with the shaft (HR=2.1; 95% CI 1.7 to 2.4). Our results are in contrast to the
findings of a US study of 240 men.7 In this highly circumcised US population, the
cumulative probability of incident HPV infection did not differ by anatomical site (44.3% in
glans vs 45.4% in shaft). Among uncircumcised men, there may be a larger disparity in HPV
acquisition by penile site, potentially attributable to keratinisation of the glans epithelium
and removal of the inner foreskin after circumcision.
Our findings indicate that less frequent bathing was a strong risk factor for HPV incidence.
These findings are similar to those in a previous report among this population that found less
frequent bathing to be the strongest risk factor for cross-sectional HPV point-prevalence.20
To our knowledge, no other studies of penile HPV acquisition among men have investigated
overall bathing frequency as a potential risk factor. Three studies of penile HPV infection
reported no association with the time since last bath or shower7 nor with genital washing
after intercourse.8, 28 Similarly, we did not find an association between the number of hours
until bathing after sex and HPV acquisition. Little is known about the effect of improved
penile hygiene on HPV infection. While bathing more frequently may not completely
prevent HPV infection in men, our findings provide evidence that more frequent bathing is
associated with a decreased risk of HPV acquisition. To assess whether more frequent
bathing reduces incident HPV infections, RCTs should be conducted to examine the effect
of male bathing on incident HPV infections. Our results indicated that men who reported a
higher number of recent sexual partners also had higher HPV IRs, as was found in previous
studies of HPV incidence in men.7, 9 We also found a slightly elevated risk of overall HPV
incidence among men who were employed, but this association was not associated with
high-risk HPV incidence.
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The 6-month interval between each visit was a limitation of this study as participants in our
study could have acquired a new HPV infection and cleared it before their subsequent
follow-up visit, potentially underestimating HPV incidence in our study. β-Globin positivity
was also relatively low in our study; however, it has been previously indicated that β-globin-
PCR-negative samples may contain detectable HPV as HPV copies may often exceed those
of the β-globin gene.20 When restricting our analyses to β-globin-positive samples, IRs for
overall HPV in the glans and shaft (47.9 and 22.4/1000 person-months, respectively) were
similar to the IRs observed in the glans and shaft among all samples (44.4 and 21.6/1000
person-months, respectively). Bathing frequency and number of recent sexual partners also
remained strong risk factors of HPV incidence among β-globin-positive samples.
The generalisability of our findings may be somewhat limited, given that participants were a
select population of primarily unmarried, uncircumcised men with at least a secondary
education who met eligibility criteria for an RCT that entailed circumcision. Uncircumcised
men may be more likely to acquire HPV infections than circumcised men10, 18 and risk
factors, such as less frequent bathing, may be modified by circumcision status; thus, caution
should be taken when comparing our findings with those of circumcised populations.
In conclusion, we found a high incidence of high-risk HPV in the glans among
uncircumcised men. Male circumcision has been found to be an effective intervention for
decreasing high-risk HPV acquisition among men.10, 18 For men who remain uncircumcised,
reducing the number of recent sexual partners and improving penile hygiene could
potentially reduce HPV acquisition.
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• Data on human papillomavirus (HPV) acquisition are needed among men from
developing regions including Africa.
• HPV incidence rates were notably high among high-risk uncircumcised men
from Kisumu, Kenya.
• Reducing the number of sexual partners and improving penile hygiene could
potentially reduce HPV acquisition among uncircumcised men.
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Table 1
Baseline characteristics of 966 uncircumcised men enrolled in the control arm of a male circumcision trial
between 2002 and 2005 in Kisumu, Kenya
Variable n (%)*
Age (years)† 20 (17–24)‡
Number of female partners in last 12 months 2 (0–28)‡
Lifetime number of female sexual partners 4 (1–86)‡
Living with female sexual partner
 No 910 (94.6)
 Yes 52 (5.4)
Education
 Primary or none 352 (36.4)
 Secondary or tertiary 614 (63.6)
Employment status
 Unemployed 623 (64.5)
 Employed 343 (35.5)
Condom use in last 6 months
 Never 219 (25.8)
 ≤50% 333 (39.2)
 >50% 298 (35.1)
Herpes simplex virus type 2 seropositive
 No 678 (73.5)
 Yes 244 (26.5)
Presence of Chlamydia trachomatis
 No 915 (96.0)
 Yes 38 (4.0)
Presence of Neisseria gonorrhoeae
 No 938 (98.4)
 Yes 15 (1.6)
Bathing frequency
 Less than daily 20 (2.1)
 Daily 937 (97.9)
*
Percentages do not include missing values for living with partner status (n=4), condom use (n=116), HSV-2 seropositivity (n=44), presence of
Chlamydia trachomatis (n=13), presence of Neisseria gonorrhoeae (n=13) and bathing frequency (n=9).
†
The study inclusion criteria required participants be aged 18–24 years; there was one protocol violation resulting in one 17-year-old included in
this study.
‡
Median (range); n=10 missing number of female partners in last 12 months; n=74 missing lifetime number of female sexual partners.
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Table 4
Risk factors of incident HPV infection at the glans or shaft over 12 months among 482 men in Kisumu,
Kenya, who were HPV-negative at the baseline visit
Baseline risk factor
Overall HPV High-risk HPV
Age-adjusted model
Age-adjusted HR (95% CI)*
Final multivariate
model
Adjusted HR (95% CI)
†
Age-adjusted model
Age-adjusted HR (95% CI)*
Final multivariate
model
Adjusted HR (95% CI)
‡
Age (years)
 17–19 1.0 (0.7 to 1.4) 1.0 (0.7 to 1.5) 1.3 (0.9 to 2.0) 1.3 (0.9 to 2.0)
 20–21 1.0 (0.7 to 1.4) 1.0 (0.7 to 1.4) 1.1 (0.8 to 1.7) 1.2 (0.8 to 1.8)
 22+ 1 1 1 1
Employment status
 Unemployed 1 1 1 1
 Employed 1.4 (1.1 to 1.9) 1.4 (1.1 to 1.9) 1.4 (1.0 to 1.9) 1.3 (0.9 to 1.9)
Education
 Primary or none 1.8 (1.0 to 3.1) 1.6 (0.8 to 3.0)
 Secondary 1.4 (0.8 to 2.4) 1.1 (0.6 to 2.1)
 Tertiary 1 1
Presence of Chlamydia trachomatis
 No 1 1
 Yes 1.9 (0.9 to 4.1) 1.8 (0.7 to 4.2)
Herpes simplex virus type 2 seropositive
 No 1 1
 Yes 1.3 (1.0 to 1.8) 1.4 (0.9 to 2.0)
Bathing frequency
 Less than daily 3.0 (1.2 to 7.9) 2.6 (1.0 to 6.5) 3.5 (1.2 to 10.1) 3.0 (1.1 to 8.4)
 Daily 1 1 1 1
Use of condom last partner
 No 1 1
 Yes 0.8 (0.6 to 1.0) 0.8 (0.5 to 1.1)
Condom use last 6 months
 Never 1 1
 ≤half time 1.3 (0.9 to 1.8) 1.5 (1.0 to 2.2)
 >half time 0.9 (0.7 to 1.3) 1.1 (0.7 to 1.6)
Lifetime # of female partners
 1 1 1
 2–5 0.9 (0.6 to 1.4) 0.9 (0.6 to 1.4)
 6+ 1.4 (1.0 to 2.1) 1.3 (0.8 to 2.1)
Partners in last 12 months
 0–1 1 1 1 1
 2+ 1.6 (1.2 to 2.2) 1.6 (1.2 to 2.1) 1.6 (1.1 to 2.3) 1.5 (1.1 to 2.2)
Living with female sexual partner
 No 1 1
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Baseline risk factor
Overall HPV High-risk HPV
Age-adjusted model
Age-adjusted HR (95% CI)*
Final multivariate
model
Adjusted HR (95% CI)
†
Age-adjusted model
Age-adjusted HR (95% CI)*
Final multivariate
model
Adjusted HR (95% CI)
‡
 Yes 1.8 (1.0 to 3.3) 1.7 (0.8 to 3.5)
Age at first intercourse
 ≤14 1.3 (0.9 to 1.8) 1.3 (0.8 to 1.9)
 15–16 1.1 (0.8 to 1.5) 1.2 (0.8 to 1.8)
 17+ 1 1
Years of sexual activity
 ≤2 1 1
 3–4 1.2 (0.8 to 1.8) 1.4 (0.9 to 2.3)
 5–6 1.1 (0.7 to 1.7) 1.3 (0.8 to 2.1)
 7+ 1.4 (0.9 to 2.1) 1.5 (0.9 to 2.6)
Paid money for sex in last 6 months
 No 1 1
 Yes 1.0 (0.6 to 1.7) 1.1 (0.7 to 1.9)
Travel to Nairobi in last 6 months
 No 1 1
 Yes 0.9 (0.6 to 1.3) 1.0 (0.7 to 1.6)
Ever tasted alcohol
 No 1 1
 Yes 1.0 (0.7 to 1.4) 1.1 (0.8 to 1.6)
Hours until washing penis after sex
 ≤1 1 1
 2–5 0.8 (0.6 to 1.2) 0.8 (0.5 to 1.2)
 6+ 1.2 (0.9 to 1.7) 1.0 (0.7 to 1.5)
Penile cuts or abrasions during sex
 Never 1 1
 Ever 1.1 (0.8 to 1.5) 1.2 (0.9 to 1.7)
Presence of sexually transmitted disease previous 6 months or current (self-reported)
 No 1 1
 Yes 0.8 (0.4 to 1.3) 0.5 (0.2 to 1.1)
*
Adjusted for age (<20, 20–21, >21 years).
†
Adjusted for age, employment status, bathing frequency and partners in last 12 months (0–1, >1 partners).
‡
Adjusted for age, bathing frequency and partners in last 12 months.
HPV, human papillomavirus.
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